ArticleOncology reports2020

Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNA‑damaging chemotherapy agents and radiation.

Zhijian Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.